Preparation of triethylenetetramine dihydrochloride for the treatment of Wilson's disease.
D002614:Chelating Agents / Q000627:therapeutic use*; D006527:Hepatolenticular Degeneration / Q000188:drug therapy*; D006801:Humans; D008722:Methods; D010880:Piperidines / Q000627:therapeutic use*; D000644:Quaternary Ammonium Compounds / Q000627:therapeutic use
D002614:Chelating Agents; D010880:Piperidines; D000644:Quaternary Ammonium Compounds